{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:59:20Z","timestamp":1791068360966,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/eurheartj\/ehr215","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T01:55:23Z","timestamp":1310003723000},"page":"2688-2696","source":"Crossref","is-referenced-by-count":130,"title":["The phosphatonin fibroblast growth factor 23 links calcium\u2013phosphate metabolism with left-ventricular dysfunction and atrial fibrillation"],"prefix":"10.1093","volume":"32","author":[{"given":"Sarah","family":"Seiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko M.","family":"Rebling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hornof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Jeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Kersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Steimle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fehrenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrill S.","family":"Rogacev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"key\n\t\t\t\t20170515123409_EHR215C1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","article-title":"Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study","volume":"52","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515123409_EHR215C2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515123409_EHR215C4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypovitaminosis D, and mortality in the United States","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","year":"2007","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2215\/CJN.01660309","article-title":"Phosphate levels and cardiovascular disease in the general population","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C8","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01250209","article-title":"Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/ATVBAHA.109.196675","article-title":"Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community","volume":"30","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C10","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123409_EHR215C11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","year":"2007","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170515123409_EHR215C12","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","article-title":"Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123409_EHR215C13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","article-title":"Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality","volume":"168","year":"2008","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170515123409_EHR215C14","first-page":"S34","article-title":"Clinical relevance of FGF-23 in chronic kidney disease","volume":"(S 114)","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","article-title":"Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23","volume":"9","year":"2005","journal-title":"Ther Apher Dial"},{"key":"key\n\t\t\t\t20170515123409_EHR215C16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","article-title":"Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules","volume":"68","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/gfp784","article-title":"The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?","volume":"25","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515123409_EHR215C18","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C20","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.2009.246","article-title":"A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C22","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515123409_EHR215C23","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123409_EHR215C24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515123409_EHR215C25","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515123409_EHR215C26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjcard.2003.09.050","article-title":"Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction","volume":"93","year":"2004","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study subjects","volume":"88","year":"1993","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123409_EHR215C28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinternmed.2009.40","article-title":"Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study","volume":"169","year":"2009","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170515123409_EHR215C29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","article-title":"Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure","volume":"116","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123409_EHR215C30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08037050152112050","article-title":"Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study","volume":"10","year":"2001","journal-title":"Blood Press"},{"key":"key\n\t\t\t\t20170515123409_EHR215C31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","article-title":"Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"156","year":"2008","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515123409_EHR215C32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0735-1097(01)01792-2","article-title":"Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction","volume":"39","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C33","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515123409_EHR215C34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515123409_EHR215C35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","year":"2009","journal-title":"Bone"},{"key":"key\n\t\t\t\t20170515123409_EHR215C36","first-page":"59","article-title":"Regulation of fibroblast growth factor 23 production in bone in uremic rats","volume":"11","year":"2009","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170515123409_EHR215C38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","article-title":"Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients","volume":"5","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI113172","article-title":"Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D","volume":"80","year":"1987","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515123409_EHR215C40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/dc09-S013","article-title":"Standards of medical care in diabetes\u20132009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170515123409_EHR215C41","first-page":"1949","article-title":"Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?","volume":"52","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2265.2007.03074.x","article-title":"Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function","volume":"68","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20170515123409_EHR215C43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515123409_EHR215C44","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","article-title":"Relationship between circulating FGF23 and total body atherosclerosis in the community","volume":"24","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515123409_EHR215C45","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515123409_EHR215C46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","volume":"69","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515123409_EHR215C47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000093277","article-title":"FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation","volume":"104","year":"2006","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20170515123409_EHR215C48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1744-9987.2005.00294.x","article-title":"Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan","volume":"9","year":"2005","journal-title":"Ther Apher Dial"},{"key":"key\n\t\t\t\t20170515123409_EHR215C49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/32\/21\/2688\/17049711\/ehr215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T02:30:46Z","timestamp":1503455446000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehr215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":49,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2011,7,6]]},"published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehr215","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}